Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Madrigal Pharmaceuticals Inc
(NQ:
MDGL
)
210.91
-4.69 (-2.18%)
Streaming Delayed Price
Updated: 3:07 PM EDT, Oct 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Madrigal Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
Next >
Ozempic Could Have a New Multibillion-Dollar Market Opportunity. Is Novo Nordisk Stock a No-Brainer Buy?
August 02, 2023
Novo Nordisk received some good news in a recent physician survey.
Via
The Motley Fool
Madrigal Stock Pops As It Makes Inroads Into What Could Be A $160 Billion Market
June 30, 2023
Madrigal is working on gaining FDA approval for what could be the first NASH treatment.
Via
Investor's Business Daily
Terns Pharmaceuticals Is "Attractively Priced" Despite Pressure From Eli Lilly's Obesity Data, Analyst Says
June 28, 2023
Tuesday, Terns Pharmaceuticals Inc (NASDAQ: TERN) shares lost more than 25% of their value due to investor pressure it faced after Eli Lilly And Co (NYSE: LLY) announced data from retatrutide that was...
Via
Benzinga
2 Growth Stocks That Doubled in 2023 and Could Shoot 55% to 87% Higher, According to Wall Street
May 30, 2023
Recent moves to the upside could be the beginning of a much larger bull run.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
May 26, 2023
Via
Benzinga
Why Madrigal Pharmaceuticals Stock Is Marching Higher Today
May 24, 2023
Two key tailwinds appear to be lifting the stock today.
Via
The Motley Fool
Analyst Expectations for Madrigal Pharmaceuticals's Future
May 16, 2023
Via
Benzinga
Why Madrigal Pharmaceuticals Stock Is Slumping Today
May 09, 2023
The biotech's shares briefly plunged following its 2023 Q1 earnings report.
Via
The Motley Fool
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 27, 2023
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health.
Via
Benzinga
Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) Making Surprising Moves in Tuesday Session
May 23, 2023
Via
Investor Brand Network
Intercept Crashes As FDA Advisors Deliver The Likely Deathblow For Its Highly Watched NASH Drug
May 22, 2023
The FDA's advisors voted resoundingly against accelerated approval for obeticholic acid.
Via
Investor's Business Daily
Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is a Leading Gainer in 3/17 Morning Trading
March 17, 2023
Via
Investor Brand Network
2 Surging Healthcare Stocks That Are Still Worth Buying
February 23, 2023
These two NASH drugmakers have a lot of room to run.
Via
The Motley Fool
Why These 3 Nasdaq Stocks Buckled Today
May 16, 2023
The FTC's decision to sue to block a high-profile merger is weighing on biotech valuations today.
Via
The Motley Fool
Viking Therapeutics Outperforms Expectations: Analyst Increases Price Target Following Successful VK2809 Trial
May 16, 2023
Ligand Pharmaceuticals Incorporated's (NASDAQ: LGND) partner Viking Therapeutics Inc (NASDAQ: VKTX) announced positive topline results from its Phase 2b trial of VK2809 in
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
April 28, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 27, 2023
Via
Benzinga
3 Biotechs That Might Get Bought Out in 2023
April 26, 2023
Biotech is expected to be a hotbed of mergers and acquisitions this year.
Via
The Motley Fool
Why Madrigal Pharmaceuticals Stock Gained 20% This Week
April 20, 2023
Two key tailwinds fueled a surge in the biotech's share price this week.
Via
The Motley Fool
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
April 20, 2023
Where is the current bull market? All indications would be that it's in biotech! The broader market is not really moving. There have been plenty of attention-grabbing headlines, and earnings season is...
Via
Benzinga
Why Top 1% Biotech Madrigal Pharmaceuticals Just Surged Closer To A Breakout
April 18, 2023
Shares are closing in on a buy point after retaking their 50-day moving average.
Via
Investor's Business Daily
Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) Making Surprising Moves in Tuesday Session
April 18, 2023
Via
Investor Brand Network
5 Best Stocks to Buy in April
April 01, 2023
These powerful trends should yield stellar returns for investors in April and beyond.
Via
The Motley Fool
Up 463%, This Sizzling Growth Stock Could Have a Lot More Room to Run
March 29, 2023
Viking Therapeutics stock might in the midst of a historic run.
Via
The Motley Fool
Is Viking Therapeutics a Smart Buy on the Dip?
March 27, 2023
The stock recently fell around 25% for reasons that had nothing to do with its lead program.
Via
The Motley Fool
Want Diversified Upside in Biotechnology? Check out LABU
March 22, 2023
Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility.
Via
MarketBeat
Topics
ETFs
Stocks
Exposures
US Equities
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
March 15, 2023
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.
Via
InvestorPlace
Intercept Tumbles As Its Experimental NASH Drug Faces Yet Another Obstacle
March 10, 2023
Meanwhile, the company is facing a stout rival in the form of Madrigal Pharmaceuticals.
Via
Investor's Business Daily
1 Incredible Growth Stock That Could Turn $200,000 Into $1 Million by 2030
March 09, 2023
This clinical-stage biopharma stock could harbor one of the best-selling drugs of all time.
Via
The Motley Fool
3 Incredible Growth Stocks to Buy if the Market Dips
March 02, 2023
These top growth stocks sport premium valuations for a very good reason.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.